Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma.
about
Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived XenograftsThe incorporation of microfluidics into circulating tumor cell isolation for clinical applications.The future of patient-derived tumor xenografts in cancer treatment.Current status and perspectives of patient-derived xenograft models in cancer research.Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study.Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.Local iontophoretic administration of cytotoxic therapies to solid tumorsCirculating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic FindingsGenomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sitesCurrent Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule.Liquid biopsy in pancreatic cancer: the beginning of a new era.The Significance of Liquid Biopsy in Pancreatic Cancer
P2860
Q28552408-F33497C7-824F-421A-B7A4-99DC17C383FEQ30364419-6306A616-A5BC-44EB-8299-79CF639B1D1AQ33361578-1442B4DE-7087-41B4-A5E8-5B3A7BC8C028Q33667686-5D8A7D87-0674-481D-81E5-F90310010501Q33868592-4873FCBC-4EFE-4631-8325-32941E153D0FQ35053624-FD7434F4-25C5-4C3B-B6E0-871BCA96CE3DQ35983594-9D844366-CF1C-4FF0-967F-5853EA10F812Q35988678-8F632539-AE7F-42B6-B802-4A59339732D7Q37086209-FDC233CE-8F77-4F85-94FA-6B3777A79FB5Q38689944-0CF8EFE9-0455-4519-B8DD-3C34A7249C95Q38726457-75D62BFB-B329-4EED-92F5-946931AB0CCCQ39385781-9A1BEB67-D94A-4558-95EA-8AC5EB9F2E78Q47449116-E0D9889E-6A08-4DC6-B713-E99DD1723370Q52808412-F55B0F66-0870-4E79-A3B9-B3603CABF58DQ55187959-78E776BE-15D9-4134-8AD6-1BC99E35325DQ57116278-4B31EE8A-8442-4033-B27C-490389DD689A
P2860
Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Circulating tumor cells as a b ...... of pancreatic adenocarcinoma.
@ast
Circulating tumor cells as a b ...... of pancreatic adenocarcinoma.
@en
type
label
Circulating tumor cells as a b ...... of pancreatic adenocarcinoma.
@ast
Circulating tumor cells as a b ...... of pancreatic adenocarcinoma.
@en
prefLabel
Circulating tumor cells as a b ...... of pancreatic adenocarcinoma.
@ast
Circulating tumor cells as a b ...... of pancreatic adenocarcinoma.
@en
P2093
P2860
P921
P1433
P1476
Circulating tumor cells as a b ...... s of pancreatic adenocarcinoma
@en
P2093
Jen Jen Yeh
Joyce W Kamande
Richard A Moffitt
Silvia G Herrera Loeza
Steven A Soper
P2860
P304
P356
10.1371/JOURNAL.PONE.0089474
P407
P577
2014-02-19T00:00:00Z